Spermosens
| Reference number | |
| Coordinator | Spermosens AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | May 2019 - January 2020 |
| Status | Completed |
| Venture | Innovative Startups |
Important results from the project
Spermosens is developing and commercializing a diagnostic device for functional male infertility. The test goes beyond conventional sperm count, morphology or motility. Instead it has been devised to probe the fusion potential of the sperms, which is the goal for male fertility testing. The current project was aimed at prototyping the diagnostic chips of the device and their functional testing. All the components of the diagnostic chips were optimized for scaling up, stability and functionality, followed by establishing fabrication protocols of the chips via industrial methods.
Expected long term effects
All the components were successfully engineered and fabricated. A feasibility analysis on the production and functionality of the diagnostic chips for the Spermosens yielded positive indication. The fabricated chips will be used for clinical studies for analysing the predictive potential of the technology. Further a route to market was also identified during this project.
Approach and implementation
The project was designed to study the feasibility of production of the biosensor chips and their testing. The optimization of bioreceptor production and purification took longer than anticipated, following which the chips were successfully produced. The functional analysis of the JUNO biosensor was also successful, and clinical testing of both the biosensors will follow.